NCT04775979View on ClinicalTrials.gov

Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 17, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

August 30, 2021

Conditions
Vitiligo
Interventions
DRUG

diphenylcyclopropenone (DPCP)

Depigmenting agent

Trial Locations (1)

Unknown

University hospitals faculty of medicine ain shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04775979 - Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo | Biotech Hunter | Biotech Hunter